Potential value of adenosine 5′-triphosphate (ATP) and adenosine in anaesthesia and intensive care medicine

British Journal of Anaesthesia

Volumn 94, Issue 5, 2005, Pages 556-562

  Skrabanja, Arno T P ^a   Bouman, E A C ^b   Dagnelie, P C ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Anaesthesia; Complications, sepsis; Nucleotide, adenosine; Nucleotide, ATP; Pain

Indexed keywords

ADENOSINE; ADENOSINE TRIPHOSPHATE; ADENOSINE TRIPHOSPHATE MAGNESIUM; KETAMINE; MORPHINE; PURINE RECEPTOR; REMIFENTANIL;

ANESTHESIA; ANTIARRHYTHMIC ACTIVITY; CARDIOVASCULAR DISEASE; CELL SECRETION; CELL SURFACE; CELL TYPE; CLINICAL STUDY; CLINICAL TRIAL; CYTOPLASM; DRUG BLOOD LEVEL; DRUG HALF LIFE; HEART FUNCTION; HEMODYNAMICS; HUMAN; INTENSIVE CARE; LOW DRUG DOSE; MUSCLE CONTRACTION; NEUROTRANSMISSION; NONHUMAN; PAIN; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW; SEPSIS; SHOCK; SIDE EFFECT; SIGNAL TRANSDUCTION; THROMBOCYTE FUNCTION; VASODILATATION;

EID: 18144375943     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/aei093     Document Type: Article

References (101)

1. Abbracchio MP, Boeynaems JM, Barnard EA, et al. Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor family. Trends Pharmacol Sci 02003; 24: 52-5
2. Agteresch HJ, Dagnelie PC, Rietveld T, van den Berg JW, Danser AH, Wilson JH. Pharmacokinetics of intravenous ATP in cancer patients. Eur J Clin Pharmacol 2000; 56: 49-55
3. Agteresch HJ, Dagnelie PC, van den Berg JW, Wilson JH. Adenosine triphosphate: established and potential clinical applications. Drugs 1999; 58: 211-32
4. Asfar P, Nalos M, Pittner A, et al. Adenosine triphosphate-magnesium dichloride during hyperdynamic porcine endotoxemia: effects on hepatosplanchnic oxygen exchange and metabolism. Crit Care Med 2002; 30: 1826-33
5. Aso Y, Tajima A, Suzuki K, et al. Intraoperative arterial pressure control by ATP in pheochromocytoma. Urology 1986; 27: 512-20
6. Barclay J, Patel S, Dorn G, et al. Functional downregulation of P2X3 receptor subunit in rat sensory neurons reveals a significant role in chronic neuropathic and inflammatory pain. J Neurosci 2002; 22: 8139-47
7. Belfrage M, Sollevi A, Segerdahl M, Sjolund KF, Hansson P. Systemic adenosine infusion alleviates spontaneous and stimulus evoked pain in patients with peripheral neuropathic pain. Anesth Analg 1995; 81: 713-17
8. Bernard GR, Macias WL, Joyce DE, Williams MD, Bailey J, Vincent JL. Safety assessment of drotrecogin alfa (activated) in the treatment of adult patients with severe sepsis. Crit Care 2003; 7: 155-63
9. Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344: 699-709
10. Boeynaems JM, Wilkin F, Marteau F, et al. P2Y receptors: new subtypes, new functions. Drug Dev Res 2003; 59: 30-5
11. Bouma MG, van den Wildenberg FA, Buurman WA. The anti-inflammatory potential of adenosine in ischemia-reperfusion injury: established and putative beneficial actions of a retaliatory metabolite. Shock 1997; 8: 313-20
12. Brady WJ, Jr, DeBehnke DJ, Wickman LL, Lindbeck G. Treatment of out-of-hospital supraventricular tachycardia: adenosine vs verapamil. Acad Emerg Med 1996; 3: 574-85
13. Brealey D, Brand M, Hargreaves I, et al. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 2002; 360: 219-23
14. Casella G, Leibig M, Schiele TM, et al. Are high doses of intracoronary adenosine an alternative to standard intravenous adenosine for the assessment of fractional flow reserve? Am Heart J 2004; 148: 590-5
15. Chaudry IH. Cellular mechanisms in shock and ischemia and their correction. Am J Physiol 1983; 245: R117-34
16. Chaudry IH. Use of ATP following shock and ischemia. Ann NY Acad Sci 1990; 603: 130-41
17. Chaudry IH, Clemens MG, Baue AE, Alterations in cell function with ischemia and shock and their correction. Arch Surg 1981; 116: 1309-17
18. 2. Adv Shock Res 1982; 8: 177-86
19. 2. Am J Physiol 1984; 246: R799-804
20. Chaudry IH, Sayeed MM, Baue AE. Depletion and restoration of tissue ATP in hemorrhagic shock. Arch Surg 1974; 108: 208-11
21. Chaudry IH, Sayeed MM, Baue AE. Evidence for enhanced uptake of ATP by liver and kidney in hemorrhagic shock. Am J Physiol 1977; 233: R83-8
22. Chen CC, Akopian AN, Sivilotti L, Colquhoun D, Burnstock G, Wood JN. A P2X purinoceptor expressed by a subset of sensory neurons. Nature 1995; 377: 428-31
23. Cikrit D, Gross K, Katz S. Comparative effects of cytoprotective agents in bowel ischemia. Surg Forum 1983; 34: 208-10
24. Coli A, Fabbri G, Lari S, Ballati S, Cipressi M, Lari F. Hypotension controlled with ATP in orthopedic surgery: incidence of atrio-ventricular conduction disorders. Minerva Anestesiol 1994; 60: 21-7
25. Colson P, Saussine M, Gaba S, Sequin J, Chaptal PA, Roquefeuil B. Vascular effects of adenosine-triphosphate. Ann Fr Anesth Reanim 1991; 10: 251-4
26. Cronstein BN, Naime D, Firestein G. The antiinflammatory effects of an adenosine kinase inhibitor are mediated by adenosine. Arthritis Rheum 1995; 38: 1040-5
27. Dagnelie PC, Sijens PE, Kraus DJ, Planting AS, van Dijk P. Abnormal liver metabolism in cancer patients detected by (31)P MR spectroscopy. NMR Biomed 1999; 12: 535-44
28. Davies DF, Gropper AL, Schroeder HA. Circulatory and respiratory effects of adenosine triphosphate in man. Circulation 1951; 3: 543-50
29. De Backer D, Creteur J, Preiser JC, Dubois MJ, Vincent JL. Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med 2002; 166: 98-104
30. Eisenach JC, Hood DD, Curry R. Preliminary efficacy assessment of intrathecal injection of an American formulation of adenosine in humans. Anesthesiology 2002; 96: 29-34
31. el Moatassim C, Dornand J, Mani JC. Extracellular ATP and cell signalling. Biochim Biophys Acta 1992; 1134: 31-45
32. Faulds D, Chrisp P, Buckley MM. Adenosine: an evaluation of its use in cardiac diagnostic procedures, and in the treatment of paroxysmal supraventricular tachycardia. Drugs 1991; 41: 596-624
33. Filkins JP, Buchanan BJ. Protection against endotoxin shock and impaired glucose homeostasis with ATP. Circ Shock 1977; 4: 253-8
34. Fredholm BB, Irenius E, Kull B, Schulte G. Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells. Biochem Pharmacol 2001; 61: 443-8
35. Fukunaga AF, Alexander GE, Stark CW. Characterization of the analgesic actions of adenosine: comparison of adenosine and remifentanil infusions in patients undergoing major surgical procedures. Pain 2003; 101: 129-38
36. Fukunaga AF, Ikeda K, Matsuda I. ATP-induced hypotensive anesthesia during surgery. Anesthesiology 1982; 57: A65
37. Fukunaga AF, Kaneko Y, Ichinohe T, Igarashi O, Nakakuki T. Intravenous ATP attenuates surgical stress responses and reduces inhalation anesthetic requirements in humans. Anesthesiology 1990; 73: A400
38. Fukunaga AF, Sodeyama O, Matsuzaki Y, et al. Hemodynamic and metabolic changes of ATP-induced hypotension during surgery. Anesthesiology 1983; 59: A12
39. Gordon JL. Extracellular ATP: effects, sources and fate. Biochem J 1986; 233: 309-19
40. Griffith MJ, Linker NJ, Ward DE, Camm AJ. Adenosine in the diagnosis of broad complex tachycardia. Lancet 1988; i: 672-5
41. Guieu R, Couraud F, Pouget J, Sampieri F, Bechis G, Rochat H. Adenosine and the nervous system: clinical implications. Clin Neuropharmacol 1996; 19: 459-74
42. Harkness RA, Coade SB, Webster AD. ATP, ADP and AMP in plasma from peripheral venous blood. Clin Chim Acta 1984; 143: 91-8
43. Harmsen E, de Jong JW, Serruys PW. Hypoxanthine production by ischemic heart demonstrated by high pressure liquid chromatography of blood purine nucleosides and oxypurines. Clin Chim Acta 1981; 115: 73-84
44. Hirasawa H, Chaundry IH, Baue AE. Improved hepatic function and survival with adenosine triphosphate-magnesium chloride after hepatic ischemia. Surgery 1978; 83: 655-62
45. 2 following hepatic ischemia. Surg Forum 1979; 30: 158-60
46. Honore P, Buritova J, Chapman V, Besson JM. UP 202-56, an adenosine analogue, selectively acts via AI receptors to significantly decrease noxiously-evoked spinal c-Fos protein expression. Pain 1998; 75: 281-93
47. Honore P, Kage K, Mikusa J, et al. Analgesic profile of intrathecal P2X(3) antisense oligonucleotide treatment in chronic inflammatory and neuropathic pain states in rats. Pain 2002; 99: 11-19
48. Jacobson KA, Jarvis MF, Williams M. Purine and pyrimidine (P2) receptors as drug targets. J Med Chem 2002; 45: 4057-93
49. Jarvis MF, Yu H, McGaraughty S, et al. Analgesic and anti-inflammatory effects of A-286501, a novel orally active adenosine kinase inhibitor. Pain 2002; 96: 107-18
50. 2 and/or inositol in rabbit lung. Circ Shock 1988; 24: 274
51. Jin X, Shepherd RK, Duling BR, Linden J. Inosine binds to A3 adenosine receptors and stimulates mast cell degranulation. J Clin Invest 1997; 100: 2849-57
52. Khakh BS, Burnstock G, Kennedy C, et al. International Union of Pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits. Pharmacol Rev 2001; 53: 107-18
53. 2 following prolonged ischemia improves myocardial performance. J Surg Res 1987; 43: 114-17
54. Kowaluk EA, Jarvis MF. Therapeutic potential of adenosine kinase inhibitors. Expert Opin Investig Drugs 2000; 9: 551-64
55. Leij-Halfwerk S, Dagnelie PC, Kappert P, Oudkerk M, Sijens PE. Decreased energy and phosphorylation status in the liver of lung cancer patients with weight loss. J Hepatol 2000; 32: 887-92
56. Lewis C, Neidhart S, Holy C, North RA, Buell G, Surprenant A. Coexpression of P2X2 and P2X3 receptor subunits can account for ATP-gated currents in sensory neurons. Nature 1995; 377: 432-5
57. McCallion K, Harkin DW, Gardiner KR. Role of adenosine in immunomodulation: review of the literature. Crit Care Med 2004; 32: 273-7
58. 2 following shock. Curr Surg 1982; 39: 82-4
59. 2 improves energetics and decreases lethality. J Surg Res 1994; 56: 537-42
60. Mulvagh SL. Advances in myocardial contrast echocardiography and the role of adenosine stress. Am J Cardiol 2004; 94: 12-17
61. Nalos M, Asfar P, Ichai C, Radermacher P, Leverve XM, Froba G. Adenosine triphosphate-magnesium chloride: relevance for intensive care. Intensive Care Med 2003; 29: 10-18
62. North RA. Molecular physiology of P2X receptors. Physiol Rev 2002; 82: 1013-67
63. 2 following hepatic ischemia. Am J Physiol 1983; 244: R695-702
64. Okada M, Kaneko S. Pharmacological interactions between magnesium ion and adenosine on monoaminergic system in the central nervous system. Magnes Res 1998; 11: 289-305
65. Ontyd J, Schrader J. Measurement of adenosine, inosine, and hypoxanthine in human plasma. J Chromatogr 1984; 307: 404-9
66. Osias MD, Siegel NJ, Chaudry IH, et al. Postischemic renal failure. Accelerated recovery with adenosine triphosphate-magnesium chloride infusion. Arch Surg 1977; 112: 729-31
67. Owall A, Gordon E, Lagerkranser M, Lindquist C, Rudehill A, Sollevi A. Clinical experience with adenosine for controlled hypotension during cerebral aneurysm surgery. Anesth Analg 1987; 66: 229-34
68. Owall A, Jarnberg PO, Brodin LA, Sollevi A. Effects of adenosine-induced hypotension on myocardial hemodynamics and metabolism in fentanyl anesthetized patients with peripheral vascular disease. Anesthesiology 1988; 68: 416-21
69. Owall A, Lagerkranser M, Sollevi A. Effects of adenosine-induced hypotension on myocardial hemodynamics and metabolism during cerebral aneurysm surgery. Anesth Analg 1988; 67: 228-32
70. Owall A, Sollevi A. Myocardial effects of adenosine- and sodium nitroprusside-induced hypotension: a comparative study in patients anaesthetized for abdominal aortic aneurysm surgery. Acta Anaesthesiol Scand 1991; 35: 216-20
71. Paskitti M, Reid KH. Use of an adenosine triphosphate-based 'cocktail' early in reperfusion substantially improves brain protein synthesis after global ischemia in rats. Neurosci Lett 2002; 331: 147-50
72. Pelleg A. Mechanisms of action and therapeutic potential of adenosine and its analogues in the treatment of cardiac arrhythmias. Coron Artery Dis 1993; 4: 109-15
73. 2 treatment prior to hypoxic-hypotension. Circ Shock 1983; 11: 65-71
74. Ralevic V, Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev 1998; 50: 413-92
75. Rankin AC, Oldroyd KG, Chong E, Rae AP, Cobbe SM. Value and limitations of adenosine in the diagnosis and treatment of narrow and broad complex tachycardias. Br Heart J 1989; 62: 195-203
76. Ryan LM, Rachow JW, McCarty BA, McCarty DJ. Adenosine triphosphate levels in human plasma. J Rheumatol 1996; 23: 214-19
77. Sawynok J. Adenosine receptor activation and nociception. Eur J Pharmacol 1998; 347: 1-11
78. Sawynok J, Reid A. Peripheral adenosine 5′-triphosphate enhances nociception in the formalin test via activation of a purinergic p2X receptor. Eur J Pharmacol 1997; 330: 115-21
79. Segerdahl M, Ekblom A, Sandelin K, Wickman M, Sollevi A. Peroperative adenosine infusion reduces the requirements for isoflurane and postoperative analgesics. Anesth Analg 1995; 80: 1145-9
80. Segerdahl M, Ekblom A, Sjolund KF, Belfrage M, Forsberg C, Sollevi A. Systemic adenosine attenuates touch evoked allodynia induced by mustard oil in humans. NeuroReport 1995; 6: 753-6
81. Segerdahl M, Ekblom A, Sollevi A. The influence of adenosine, ketamine, and morphine on experimentally induced ischemic pain in healthy volunteers. Anesth Analg 1994; 79: 787-91
82. Segerdahl M, Irestedt L, Sollevi A. Antinociceptive effect of perioperative adenosine infusion in abdominal hysterectomy. Acta Anaesthesiol Scand 1997; 41: 473-9
83. Segerdahl M, Persson E, Ekblom A, Sollevi A. Peroperative adenosine infusion reduces isoflurane concentrations during general anesthesia for shoulder surgery. Acta Anaesthesiol Scand 1996; 40: 792-7
84. Shapiro MJ, Jellinek M, Pyrros D, Sundine M, Baue AE. Clearance and maintenance of blood nucleotide levels with adenosine triphosphate-magnesium chloride injection. Circ Shock 1992; 36: 62-7
85. 2 restores gut absorptive capacity early after trauma-hemorrhagic shock. Am J Physiol 1993; 264: R977-83
86. Sollevi A, Belfrage M, Lundeberg T, Segerdahl M, Hansson P. Systemic adenosine infusion: a new treatment modality to alleviate neuropathic pain. Pain 1995; 61: 155-8
87. Sollevi A, Lagerkranser M, Irestedt L, Gordon E, Lindquist C. Controlled hypotension with adenosine in cerebral aneurysm surgery. Anesthesiology 1984; 61: 400-5
88. Sommerschild HT, Kirkeboen KA. Adenosine and cardio-protection during ischaemia and reperfusion - an overview. Acta Anaesthesiol Scand 2000; 44: 1038-55
89. Spronk PE, Ince C, Gardien MJ, Mathura KR, Oudemans-van Straaten HM, Zandstra DF. Nitroglycerin in septic shock after intravascular volume resuscitation. Lancet 2002; 360: 1395-6
90. Thiel M, Caldwell CC, Sitkovsky MV. The critical role of adenosine A(2A) receptors in downregulation of inflammation and immunity in the pathogenesis of infectious diseases. Microbes Infect 2003; 5: 515-26
91. Torrance JD, Whittaker D. Distribution of erythrocyte nucleotides in pyrimidine 5′-nucleotidase deficiency. Br J Haematol 1979; 43: 423-34
92. Torssell L, Ekestrom S, Sollevi A. Adenosine-induced increase in graft flow during coronary bypass surgery. Scand J Thorac Cardiovasc Surg 1989; 23: 235-9
93. Trams EG. A proposal for the role of ecto-enzymes and adenylates in traumatic shock. J Theor Biol 1980; 87: 609-21
94. Traut TW. Physiological concentrations of purines and pyrimidines. Mol Cell Biochem 1994; 140: 1-22
95. Vincent JL. Update on sepsis: pathophysiology and treatment. Acta Clin Belg 2000; 55: 79-87
96. von Kugelgen I, Wetter A. Molecular pharmacology of P2Y-receptors. Naunyn Schmiedebergs Arch Pharmacol 2000; 362: 310-23
97. Wang B, Tang J, White PF, et al. The effect of GP683, an adenosine kinase inhibitor, on the desflurane anesthetic requirement in dogs. Anesth Analg 1997; 85: 675-80
98. 2 on the depressed endothelium-dependent relaxation during hyperdynamic sepsis. Crit Care Med 1999; 27: 959-64
99. Woolf CJ, Chong MS. Preemptive analgesia - treating postoperative pain by preventing the establishment of central sensitization. Anesth Analg 1993; 77: 362-79
100. Zaki MS, Burke JF, Trelstad RL. Protective effects of adenosine triphosphate administration in burns. Arch Surg 1978; 113: 605-10
101. Zhu CZ, Mikusa J, Chu KL, et al. A-134974: a novel adenosine kinase inhibitor, relieves tactile allodynia via spinal sites of action in peripheral nerve injured rats. Brain Res 2001; 905: 104-10